CTW0404

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

CTW0404
Identifiers
  • (2S,4R)-N-(2-morpholin-4-ylethyl)-4-(2-phenylethyl)piperidine-2-carboxamide
PubChem CID
ChemSpider
ChEMBL
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC20H31N3O2
Molar mass345.487 g·mol−1
3D model (JSmol)
  • C1CN[C@@H](C[C@@H]1CCC2=CC=CC=C2)C(=O)NCCN3CCOCC3
  • InChI=1S/C20H31N3O2/c24-20(22-10-11-23-12-14-25-15-13-23)19-16-18(8-9-21-19)7-6-17-4-2-1-3-5-17/h1-5,18-19,21H,6-16H2,(H,22,24)/t18-,19+/m1/s1
  • Key:YQSGRDPBXKGAPX-MOPGFXCFSA-N

CTW0404 is an experimental drug which is described as a positive allosteric modulator of the 5-HT2A receptor, with neutral or negative modulation of the related 5-HT2B and 5-HT2C subtypes. It does not produce the head-twitch response in animal studies, and reduces the head-twitch response produced by DOI, suggesting that it may be a biased allosteric modulator selective for certain signalling pathways.[1][2][3][4]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  2. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  3. ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
  4. ^ WO 2023/023287, Zhou J, Cunningham KA, Bolinger AA, Anastasio NC, "Novel heterocyclic compounds as serotonin (5-ht) 5-ht2a and 5-ht2c receptor positive allosteric modulators.", published Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value)., assigned to The Board of Regents of the University of Texas System